In the first part of Generics Bulletin’s newly-compiled top 50 ranking for the off-patent industry, we brought you details of the top ten generics and biosimilars firms and showed how recent events had affected companies at the top of the table. (Also see "A Year Of Surprises Shakes Up Industry Top 10" - Generics Bulletin, 19 August, 2020.)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?